India's Health Ministry warns pharma firms against promoting prescription weight-loss drugs publicly The CDSCO advises no direct or indirect advertising of GLP-1 receptor agonists for obesity Obesity treatment must focus on lifestyle changes alongside medication, not drugs alone
